A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury.
about
Degenerative cervical myelopathyRecent advances in managing a spinal cord injury secondary to traumaCervical spinal cord injury: tailoring clinical trial endpoints to reflect meaningful functional improvementsRationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial.The Sur1-Trpm4 Channel in Spinal Cord InjuryMRI evidence that glibenclamide reduces acute lesion expansion in a rat model of spinal cord injury.Recent advances in the pharmacologic treatment of spinal cord injurySpinal cord injury causes chronic liver pathology in rats.Riluzole is a promising pharmacological inhibitor of bilirubin-induced excitotoxicity in the ventral cochlear nucleus.Protection and Repair After Spinal Cord Injury: Accomplishments and Future Directions.A Direct Comparison of Three Clinically Relevant Treatments in a Rat Model of Cervical Spinal Cord Injury.A Systematic Review of Experimental Strategies Aimed at Improving Motor Function after Acute and Chronic Spinal Cord Injury.Diadenosine tetraphosphate (Ap4A) inhibits ATP-induced excitotoxicity: a neuroprotective strategy for traumatic spinal cord injury treatment.Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to II.Riluzole as a neuroprotective drug for spinal cord injury: from bench to bedside.Surgical Neurostimulation for Spinal Cord Injury.Intramedullary Lesion Length on Postoperative Magnetic Resonance Imaging is a Strong Predictor of ASIA Impairment Scale Grade Conversion Following Decompressive Surgery in Cervical Spinal Cord Injury.Assessment and management of acute spinal cord injury: From point of injury to rehabilitation.Traumatic spinal cord injury: current concepts and treatment update.Predicting task performance from upper extremity impairment measures after cervical spinal cord injury.Effects of Pain and Pain Management on Motor Recovery of Spinal Cord-Injured Patients: A Longitudinal Study.Riluzole Serum Concentration in Pediatric Patients Treated for Obsessive-Compulsive Disorder.Sulfonylureas--a novel treatment to reduce tissue damage after acute spinal cord injury?Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury.The antioxidant effects of riluzole on the APRE-19 celll model injury-induced by t-BHP.Granulocyte Colony-Stimulating Factor (G-CSF) for the Treatment of Spinal Cord Injury.Mechanism of Neuroprotection Against Experimental Spinal Cord Injury by Riluzole or Methylprednisolone.Translational Advances in the Management of Acute Spinal Cord Injury: What is New? What is Hot?Stem Cells Therapy for Spinal Cord Injury.Cleavage of Na(+) channels by calpain increases persistent Na(+) current and promotes spasticity after spinal cord injury.Riluzole Can Improve Sensory and Motor Function in Patients with Acute Spinal Cord InjuryTraumatic spinal cord injury
P2860
Q26744169-5403E201-4D35-47BB-AD8B-35497A4E2AA8Q26745909-CBA41C4B-C412-4BAF-987F-624A4E3D9637Q26823368-84120152-0038-4020-8AB3-E45506A0994BQ33586608-6FA3592D-3347-4B01-B352-C92C4020A762Q33602457-4C802987-8C95-432F-8B73-956A9E818AE9Q33825191-9066055E-3BB0-4C3A-84C5-A00B8E2D8972Q34518608-41B445E6-A30B-4595-8645-CD5D4C39B552Q34983871-01D7F189-FEB7-418B-B01D-B668E4A4BB79Q35509970-8D5A4AE2-97A4-49F0-9870-70264F07DA00Q36054971-B607D4CC-EBEB-4DA4-9CF6-CA8AF740B3F1Q36263581-AD673F49-6110-44A8-B062-4F3BA56CBEA1Q36654629-03FF6F8A-0918-4C97-B26F-3CFDBCD3A3F8Q37677819-0BD2A38F-2846-4F91-99B8-0C2A01A47083Q38342072-2F9CE795-0BDF-46A7-B4E6-7F8B48B9D068Q38457735-65AFD45B-6296-420B-BCE8-DFC0DDABF669Q38756507-AE2CF407-CB69-4BE9-A456-D9C41EBC144DQ38864592-9A674848-9047-436E-A6EF-D2EBF23B1F24Q39344452-219829DE-4059-4446-9450-E40DA9A8DB22Q39402793-E616166C-C452-4731-95CF-085A1636722EQ39724770-FA612588-BA55-40B3-8258-649E44FE0EDCQ40127495-73CAFE09-33F7-47CE-BFB8-24080A9F69A4Q42697702-8104DDE2-3D70-4606-A2BF-A02395D5484AQ43105719-18736807-ECBC-41AB-8371-58708B7863B1Q47106198-740382AB-3656-4B98-9796-4F3561A2ED35Q47140150-0D838FD1-625C-44D6-8BB7-2B05765DCBB5Q47566621-C402264E-EB9C-4685-BDAE-B88E0D1E33C5Q48327595-8BDFF44C-AB25-4C7F-B754-FAB36875401DQ50130531-6858B446-D593-4641-B15B-7ADFB5ACC9C7Q52619084-C44040A9-8053-4789-B87B-39A9A26D1D8FQ52880821-6BE4DE82-993D-4070-A9E0-A6117946C96CQ57141481-EA110484-0D94-4242-B313-5C7004D16DDDQ57838429-4A01FDE0-594C-4681-AFBB-8153A6C0492B
P2860
A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A prospective, multicenter, ph ...... traumatic spinal cord injury.
@ast
A prospective, multicenter, ph ...... traumatic spinal cord injury.
@en
type
label
A prospective, multicenter, ph ...... traumatic spinal cord injury.
@ast
A prospective, multicenter, ph ...... traumatic spinal cord injury.
@en
prefLabel
A prospective, multicenter, ph ...... traumatic spinal cord injury.
@ast
A prospective, multicenter, ph ...... traumatic spinal cord injury.
@en
P2093
P2860
P921
P356
P1476
A prospective, multicenter, ph ...... traumatic spinal cord injury.
@en
P2093
Angela Teng
Bizhan Aarabi
Charles Tator
Christopher I Shaffrey
Diana S L Chow
Elizabeth G Toups
James D Guest
James S Harrop
Jefferson R Wilson
Keith D Burau
P2860
P304
P356
10.1089/NEU.2013.2969
P577
2013-10-11T00:00:00Z